Evidence map›Paper›PMID 26106909›Full record

ArticleMolecular pharmaceutics2015

Microarray Determination of the Expression of Drug Transporters in Humans and Animal Species Used for the Investigation of Nasal Absorption.

Manar Al-Ghabeish, Todd Scheetz, Mahfoud Assem, Maureen D Donovan

Open access · greenAbstract read
In one paragraph

Article in Molecular pharmaceutics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Article
  3. Transporter-Mediated Drug Delivery.Molecules (Basel, Switzerland) · 2023
    Review
  4. Article
  5. Is RPMI 2650 a Suitable In Vitro Nasal Model for Drug Transport Studies?European journal of drug metabolism and pharmacokinetics · 2018
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Manar Al-Ghabeish†Division of Pharmaceutics and Translational Therapeutics, University of Iowa, Iowa City, Iowa 52242, United States.
Todd Scheetz‡Department of Biomedical Engineering, Department of Ophthalmology and Visual Sciences, and Center for Bioinformatics and Computational Biology, University of Iowa, Iowa City, Iowa 52242, United States.
Mahfoud Assem†Division of Pharmaceutics and Translational Therapeutics, University of Iowa, Iowa City, Iowa 52242, United States.
Maureen D Donovan†Division of Pharmaceutics and Translational Therapeutics, University of Iowa, Iowa City, Iowa 52242, United States.
University of Iowa · USTranslational Therapeutics (United States) · US

Funding

Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Brandi Janssen · 1990 to 2026
$40.5M
Bypassing the Blood-Brain Barrier:Modulation of Transporters in the Nasal MucosR01DC008374 · NIDCD · UNIVERSITY OF IOWA · PI DONOVAN, MAUREEN D · 2007 to 2011
$1.6M
NIDCD NIH HHS R01 DC008374NIDCD NIH HHS R01DC08374NIEHS NIH HHS P30 ES005605
6 · The paper itself

Abstract

Mice and rats are commonly used to investigate in vivo nasal drug absorption, yet their small nasal cavities limit their use for in vitro investigations. Bovine tissue explants have been used to investigate drug transport through the nasal respiratory and olfactory mucosae, yet limited information is available regarding the similarities and differences among these animal models compared to humans. The aim of this study was to compare the presence of a number of important drug transporters in the nasal mucosa of these species. DNA microarray results for nasal samples from humans, rats, and mice were obtained from GenBank, while DNA microarray and RT-PCR were performed on bovine nasal explants. The drug transporters of interest include multidrug resistance, cation, anion, peptide, and nucleoside transporters. Each of the species (mouse, rat, cattle, and human) shows similar patterns of expression for most of the important drug transporters. Several transporters were highly expressed in all the species, including MRP1, OCTN2, PEPT2, and y+LAT2. While some differences in transporter mRNA and protein expression were observed, the transporter expression patterns were quite similar among the species. The differences suggest that it is important to be aware of any specific differences in transporter expression for a given compound being investigated, yet the similarities support the continued use of these animal models during preclinical investigation of intranasally administered therapeutics.

Indexed as

Gene Expression ProfilingOligonucleotide Array Sequence AnalysisAdministration, IntranasalAnimalsATP-Binding Cassette, Sub-Family C ProteinsBiological TransportCattleHumansMiceNasal AbsorptionNasal MucosaNucleoside Transport ProteinsOrganic Cation Transport ProteinsRatsSpecies SpecificityATP-Binding Cassette, Sub-Family C ProteinsNucleoside Transport ProteinsOrganic Cation Transport Proteinsanimal modelsdrug transportersmicroarraynasal mucosaRT-PCR

Identifiers

PMID26106909
PMCPMC4671632
OpenAlexW2342244932

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.